The Danish healthcare company’s stock slumped on Friday after it announced the Phase 3 trial failure.
The Danish healthcare company’s stock slumped on Friday after it announced the Phase 3 trial failure.
Join thousands of traders and investors. Discover how specific trading strategies work — and get started with your investment journey.
